Sponsored Links
| Merck And Hanwha Chemical Corporation Establish Global Strategic Collaboration To Develop And Commercialize Biosimilar Candidate |
 |
 |
 |
| Medical News - Biology and Biochemistry | |||
|
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Hanwha Chemical Corporation (KOSPI: 09830) today announced that they have entered into an exclusive global agreement to develop and commercialize a candidate biosimilar form of Enbrel® (etanercept)... Read more: Biology / Biochemistry News From Medical News Today
|